Back to results
US 2012/0238591 A1Published application
Acyclovir formulations
AssigneeEmisphere Technologies, Inc.
InventorsShingai MAJURU, Moses Oyewumi
Life of this patent
Estimating the term…
Abstract
The present invention relates to acyclovir formulations having improved bioavailability resulting in better efficacy and/or requiring less frequent administration.
Claims25
A solid pharmaceutical composition comprising:
- (a) SNAC;
- (b) acyclovir;
- and
- (c) a disintegrant,
- wherein the SNAC and acyclovir are at least substantially dissolved within an hour of contact with an aqueous medium.
2 more elements
(canceled)
6-8. (canceled)
(canceled)
(canceled)
33-48. (canceled)
A pharmaceutical composition comprising:
- (a) acyclovir;
- (b) SNAC;
- (c) croscarmellose sodium;
- (d) povidone;
- (e) pregelatinized starch;
- (f) fumed silica.
3 more elements
50-57. (canceled)
Dependencies are inferred from the claim text.